Palliative Care Intervention in Patients With Solid Tumors Participating in Phase I Clinical Trials - Trial NCT01612598
Access comprehensive clinical trial information for NCT01612598 through Pure Global AI's free database. This phase not specified trial is sponsored by City of Hope Medical Center and is currently Completed. The study focuses on Unspecified Adult Solid Tumor, Protocol Specific. Target enrollment is 16 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
City of Hope Medical Center
Timeline & Enrollment
N/A
Jul 01, 2012
Jan 01, 2014
Primary Outcome
Study accrual and retention,Change in psychological distress assessed using Distress Thermometer,Change in satisfaction with communication assessed using Satisfaction with Communication Tool,Change in QOL using Functional Assessment of Cancer Therapy- General (FACT-G) and Functional Assessment of Chronic Illness Therapy- Spirituality (FACT-Sp-12),Change in symptom intensity and distress using Memorial Symptom Assessment Scale (MSAS)
Summary
Patients enrolled in phase I clinical trials could potentially benefit from palliative care
 concurrently, yet limited evidence is available to support such a change in care. The primary
 purpose of this study is to test the feasibility of a palliative care intervention (PCI) for
 patients participating in a phase I therapeutic clinical trial
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT01612598
Non-Device Trial